01 5Premarin family
Main Therapeutic Indication : Urology
Currency : USD
2020 Revenue in Millions : 680
2019 Revenue in Millions : 734
Growth (%) : -7
Main Therapeutic Indication : Urology
Currency : USD
2021 Revenue in Millions : 563
2020 Revenue in Millions : 680
Growth (%) : -17
Main Therapeutic Indication : Women's Health
Currency : USD
2022 Revenue in Millions : 455
2021 Revenue in Millions : 563
Growth (%) : -19
Main Therapeutic Indication : Women's Health
Currency : USD
2023 Revenue in Millions : 397
2022 Revenue in Millions : 455
Growth (%) : -13
Main Therapeutic Indication : Urology
Currency : USD
2019 Revenue in Millions : 734
2018 Revenue in Millions : 832
Growth (%) : -12
LOOKING FOR A SUPPLIER?